Galectin Therapeutics Provides Corporate Update MarketWatch (press release) Currently, nearly 500000 patients have cirrhosis with nearly 50000 losing their lives yearly in the United States; while only 6200 were saved by liver transplantation at a cost of $350000 per transplantation. The driving factor for our commitment to ... |
